Organisation › Details

Quotient Bioresearch Ltd.

http://www.quotientbioresearch.com

Quotient Bioresearch is a leading provider of early stage and specialist drug development services to life science clients worldwide. Formed in early 2007, Quotient initially pursued a buy-and-build strategy and has since been consolidating and integrating the acquired businesses. Quotient has benefitted from significant investment in its facilities in the last few years providing: - One of the world's most extensive bioanalytical facilities, spanning small molecules, biopharmaceuticals, molecular biology and antimicrobials. - A unique approach to early Clinical development, combining expertise in formulation, manufacturing, drug delivery and clinical studies into a single service; and - The world's leading custom radiolabelling facility, including a brand-new GMP facility. Quotient provides tailored solutions for pharmaceutical, biotechnology and agrochemical clients, using state-of-the-art technologies underpinned by unparalleled medical, chemical and biological expertise. These can be provided independently or integrated into bespoke work programmes. *

	Start	2007-01-25 established
	Group	Quotient Bioresearch (Group)
	Industry	genomics
	Person	Burdett, Roger (Quotient Bioresearch 201201 CEO)
	Person 2	Cameron, Gordon (Quotient Bioresearch 2007– CFO before Acambis 2004–200706 CEO before CFO before NM Rothschild)

	Region	Fordham, Cambridgeshire
	Country	United Kingdom (GB)
	Street	Newmarket Road
	City	CB7 5WW Fordham
		Address record changed: 2012-02-08

Basic data	Employees	n. a.

		* Document for »About Section«: Quotient Bioresearch Ltd.. (1/23/12). "Press Release: Quotient Bioresearch Secures Investment for Next Phase of Growth". Cambridgeshire.

		Record changed: 2012-05-06

Follow Us!

Top News

Upcoming Events

Associations

Partners

Quotient Bioresearch Ltd.

More documents for Quotient Bioresearch (Group)